Panel Discussion: Reviewing Biomarkers Discussed in the Context of Fibrosis & Oncology

Time: 11:45 am
day: Day One


• Highlighting promising new avenues for evaluating fibrosis staging in vivo, in vitro and in patient
• Reviewing the advantages and pitfalls of fluid markers vs imaging for fibrosis diagnostics
• Illuminating similarities and differences in biomarkers across fibrotic disease and tumor fibrosis